FIELD: medicine.
SUBSTANCE: diagnosing severe late gestosis is ensured by biochemical ELISA blood assay of a pregnant woman on her third trimester to determine the concentration of leptin and ghrelin hormones in venous blood. If observing the concentration of blood serum leptin hormone more than 37.89 ng/ml in a combination with decreasing the concentration of blood plasma ghrelin hormone less than 0.26 ng/ml, severe gestosis is diagnosed.
EFFECT: method provides more reliable diagnosis of severe gestosis to determine an approach to pregnancy management.
3 cl, 8 dwg, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSTIC TECHNIQUE FOR PREECLAMPSIA IN PREGNANT WOMEN SUFFERING CHRONIC ARTERIAL HYPERTENSION | 2014 |
|
RU2561060C1 |
| METHOD OF DIAGNOSING SEVERE PREECLAMPSIA | 2015 |
|
RU2587781C1 |
| METHOD OF DIAGNOSTICS OF PREECLAMPSIA ATTACHMENT IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2016 |
|
RU2652447C1 |
| METHOD FOR PREDICTING THE RISK OF PREECLAMPSIA IN PREGNANT WOMEN WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS | 2020 |
|
RU2751139C1 |
| METHOD FOR FORECASTING DEVELOPMENT OF PRE-ECLAMPSIA IN LATE PREGNANCY | 2018 |
|
RU2691114C1 |
| METHOD FOR FORECASTING SEVERITY OF EARLY PREECLAMPSY | 2021 |
|
RU2753463C1 |
| METHOD FOR PREDICTING THE RECURRENCE OF EARLY PREECLAMPSIA BY MARKERS OF ENDOTHELIAL DYSFUNCTION | 2022 |
|
RU2795090C1 |
| METHOD FOR PREDICTION OF ONSET OF GESTOSIS IN PREGNANT WOMEN | 2011 |
|
RU2478960C2 |
| METHOD FOR PREECLAMPSIA SEVERITY ASSESSMENT BY RELATIVE CONTENT OF CD16+ MONOCYTES IN PERIPHERAL BLOOD OF PREGNANT WOMEN | 2019 |
|
RU2712228C1 |
| DIAGNOSTIC TECHNIQUE OF PREECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2012 |
|
RU2483311C1 |
